Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Xilio Therapeutics, Inc.

Pharmaceutical Preparations · Waltham, MA, United States

  1. PrincipalsChristopher James FrankenfieldChief Financial OfficerKatarina LuptakovaCHIEF MEDICAL OFFICERRene RussoPRESIDENT AND CEOand 2 more
  2. CompanyXilio Therapeutics, Inc.Waltham, MA, United States
  3. Phone line+1 (617) 833-1027General business
Request a quote

Xilio Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker XLO) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 5

Chief executive

Rene RussoPRESIDENT AND CEO

Chair & board

James Samuel ShannonDirector (Board)

Finance

Christopher James FrankenfieldChief Financial Officer
Everyone else on file (2)
Katarina LuptakovaCHIEF MEDICAL OFFICER
Kevin M. BrennanSVP, FINANCE AND ACCOUNTING

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Christopher James Frankenfield — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Katarina Luptakova — CHIEF MEDICAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Kevin M. Brennan — SVP, FINANCE AND ACCOUNTING

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers